Literature DB >> 26286069

Short stature in retinoblastoma survivors: a cross-sectional study of 138 patients.

A Batra1, M Patekar1, S Bakhshi2.   

Abstract

PURPOSE: Short stature has been reported in pediatric cancer survivors. Data on retinoblastoma survivors are limited. We conducted a cross-sectional study to assess the height in retinoblastoma survivors.
METHOD: The recorded height was compared with median height for age and sex as per the Indian Academy of Pediatrics. Z-score less than -2 was considered short statured. RESULT: Thirty percent of the survivors were short statured. The mean height was shorter than the mean 50th percentile height (119.7 ± 14.8 vs 128.7 ± 15 cm, p < 0.001). Previous chemotherapy showed a trend toward association (p = 0.09).
CONCLUSION: Short stature affects a significant number of retinoblastoma survivors.

Entities:  

Keywords:  Long-term effects; Retinoblastoma; Short stature; Survivorship

Mesh:

Year:  2015        PMID: 26286069     DOI: 10.1007/s12094-015-1380-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  19 in total

1.  Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.

Authors:  Eric J Chow; Debra L Friedman; Yutaka Yasui; John A Whitton; Marilyn Stovall; Leslie L Robison; Charles A Sklar
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

2.  Adult height and age at menarche in childhood cancer survivors.

Authors:  E M Noorda; R Somers; F E van Leeuwen; T Vulsma; H Behrendt
Journal:  Eur J Cancer       Date:  2001-03       Impact factor: 9.162

Review 3.  Current update on retinoblastoma.

Authors:  Samuel K Houston; Timothy G Murray; Stacey Quintero Wolfe; Cristina E Fernandes
Journal:  Int Ophthalmol Clin       Date:  2011

4.  Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia.

Authors:  N H Birkebaek; N Clausen
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

5.  Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation.

Authors:  C Sklar; A Mertens; A Walter; D Mitchell; M Nesbit; M O'Leary; R Hutchinson; A Meadows; L Robison
Journal:  J Pediatr       Date:  1993-07       Impact factor: 4.406

6.  Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.

Authors:  Virginia Kimball Dalton; Montse Rue; Lewis B Silverman; Richard D Gelber; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall Schorin; Nancy J Tarbell; Stephen E Sallan; Laurie E Cohen
Journal:  J Clin Oncol       Date:  2003-08-01       Impact factor: 44.544

7.  Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study.

Authors:  A C Hokken-Koelega; J W van Doorn; K Hählen; T Stijnen; S M de Muinck Keizer-Schrama; S L Drop
Journal:  Pediatr Res       Date:  1993-06       Impact factor: 3.756

8.  Growth in children treated for acute lymphoblastic leukaemia.

Authors:  P E Clayton; S M Shalet; P H Morris-Jones; D A Price
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

9.  Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia.

Authors:  E A Schriock; M J Schell; M Carter; O Hustu; J J Ochs
Journal:  J Clin Oncol       Date:  1991-03       Impact factor: 44.544

10.  Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study.

Authors:  James G Gurney; Kirsten K Ness; Marilyn Stovall; Suzanne Wolden; Judy A Punyko; Joseph P Neglia; Ann C Mertens; Roger J Packer; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.